Trenton Thomas Ross

Title: Trenton Thomas Ross: Innovator in Pharmaceutical Treatments

Introduction

Trenton Thomas Ross is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of liver diseases. With a total of 2 patents, Ross is recognized for his innovative approaches to medical treatments.

Latest Patents

Ross's latest patents focus on combinations for the treatment of non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD). One of his patents describes a combination of (S)-2-(5-((3-ethoxypyridin-2-yl)oxy)pyridin-3-yl)-N-(tetrahydrofuran-3-yl)pyrimidine-5-carboxamide or its pharmaceutically acceptable salt, along with 4-(4-(1-Isopropyl-7-oxo-1,4,6,7-tetrahydrospiro[indazole-5,4'-piperidine]-1′-carbonyl)-6-methoxypyridin-2-yl)benzoic acid or its pharmaceutically acceptable salt. This combination aims to provide effective treatment options for diseases affecting the liver in mammals.

Career Highlights

Trenton Thomas Ross is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development in medical treatments.

Collaborations

Ross has worked alongside William Paul Esler, enhancing the collaborative efforts in their research projects. Their combined expertise has led to advancements in the understanding and treatment of liver diseases.

Conclusion

Trenton Thomas Ross is a prominent inventor whose work in pharmaceutical innovations is making a significant impact on the treatment of liver diseases. His contributions through patents and collaborations highlight the importance of research in advancing medical science.